Search Share Prices
AZN Shares - Addition by subtraction: AstraZeneca continues to slim down
This is part of the Anglo-Swedish giant's focus on its core R&D portfolio and bunch blockbusters it owns As part of its focus on its core drugs portfolio, AstraZeneca PLC (LON:AZN) is divesting the US ...
Psoriasis Drugs Market Growth at a CAGR 9.8%, Research Methodology, Growth Drivers, Recent Changes and Developments in the Market, 2019-2027
(lon:GSK), Johnson & Johnson Services, Inc. JNJ, -0.19%, Amgen Inc. AMGN, +0.08%, Celgene Corporation, AbbVie Inc. ABBV, -0.68%, Eli Lilly and Company LLY, -0.08%, AstraZeneca (lon:AZN) and Biocon ...
AstraZeneca cancer drug fast-tracked by the FDA
Anglo-Swedish drugs giant AstraZeneca PLC (LON:AZN) has been granted a priority review for a new drug’s use in a particularly aggressive and untreated form of lung cancer. Imfinzi, which is already ...
Shore Capital Reaffirms Buy Rating for AstraZeneca (LON:AZN)
AstraZeneca (LON:AZN)‘s stock had its “buy” rating reaffirmed by investment analysts at Shore Capital in a research note issued to investors on Friday, ThisIsMoney.Co.Uk reports. Other equities ...
Why the Astrazeneca share price (LON:AZN) could go higher
The rational investor can take advantage of this mispricing. Stockopedia’s Momentum Rank is a convenient way of summarising the momentum attributes of a stock - let’s use Astrazeneca (LON:AZN) as an ...